Best Tumor marker CA 19-9 Doctors Worldwide — TOP 16

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental. He specializes in gastrointestinal malignancies where tumor marker CA 19-9 testing is vital.

• Trained at the University of Texas MD Anderson Cancer Center in the USA
• Completed a specialized oncology fellowship at the Hacettepe University Cancer Institute
• Treats complex gastrointestinal cancers including stomach, colon, and pancreatic tumors
• Uses evidence-based medical therapies for advanced cancer staging and monitoring
• Expert in coordinating systemic treatments like immunotherapy and targeted therapy

Dr. Suleyman Hilmi Aksoy is an Assistant Professor at Cerrahpasa Medical Faculty. He specializes in interventional radiology at Hisar Hospital Intercontinental.

• Provides teleradiology services for remote analysis of Tumor marker CA 19-9 results
• Leads whole-body imaging using MRI and CT scans for precise diagnostic mapping
• Member of the European Society of Radiology which sets high imaging standards
• Presented academic research at 13 national and international medical congresses
• Maintains memberships in both the International and Turkish Societies of Radiology

Associate Professor Tahsin Ozatli specializes in gastrointestinal cancer care at Istinye University Liv Hospital. This expertise is vital for interpreting CA 19-9 tumor marker results in digestive health.

• Previously served as a physician at the specialized Ankara Oncology Clinic in Turkey
• Focuses on diagnosing and treating lung and gastrointestinal system cancers
• Worked as an internal medicine specialist at Malatya State Hospital
• Former physician at the Erzurum Regional Training and Research Hospital oncology department

Dr. Elnur Sahibov is a radiation oncology specialist at Emsey Hospital. He uses his expertise to monitor tumor marker CA 19-9 levels during cancer care.

• Completed specialization training at Marmara University Faculty of Medicine
• Focuses on radiation oncology – using high-energy radiation to treat cancer
• Trained at an English-language medical faculty at Marmara University
• Practices at Emsey Hospital – a major private medical center in Turkey

Dr. Shruti Kate is the Head of Department at HCG Manavata Cancer Centre. She specialized in medical oncology at Tata Memorial Hospital – India's premier cancer treatment facility.

• Evaluates tumor marker CA 19-9 levels for pancreatic and gastrointestinal cancers
• Performs the Whipple procedure – a complex surgery for tumors in the pancreas
• Awarded a solo travel grant for research at the World Conference on Lung Cancer
• Member of ASCO, the world's leading professional organization for oncology
• Expert in immunotherapy – uses the immune system to fight aggressive cancer cells

Dr. Antonio Cubillo Gracián leads the Medical Oncology Service at HM Sanchinarro. He pioneered a liquid biopsy program in Spain for blood-based molecular tumor analysis.

• Specializes in cancers of the digestive system, including the liver, stomach, and colon
• Uses the CA 19-9 tumor marker to monitor digestive system pathologies
• Director of Postgraduate Research at the HM CIOCC cancer center
• Associate Professor of Oncology teaching pathology and oncology practices at USP CEU
• Investigates new therapies as a co-investigator for the Start Madrid clinical trials program

Professor Ersin Ozturk completed a colorectal research fellowship at the Cleveland Clinic. He focuses on digestive tract cancers at Medicana Bursa Hospital where CA 19-9 markers are monitored.

• Specializes in surgical oncology for stomach, liver, and pancreatic cancers
• PhD in Physiology – uses depth of knowledge to manage complex digestive cases
• Performs laparoscopic surgery – minimally invasive techniques for faster recovery
• Expert in hepatobiliary procedures involving the liver, gallbladder, and bile ducts
• Member of the medical faculty at KTO Karatay University School of Medicine

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages tumor marker CA 19-9 testing for monitoring gastrointestinal and pancreatic cancers.

• Completed a post-doctoral fellowship in thermoradiotherapy at Thomas Jefferson University in the USA
• Former Coordinator of Oncological Sciences at Anadolu Medical Center for 13 years
• Specializes in treating gastrointestinal tumors including cancers of the stomach and liver
• Previously served as Chairman of Radiation Oncology at Uludağ University Medical College
• Conducted research on cancer risks at the National Cancer Institute in the USA

Dr. Sridhar P.S. is a specialist in radiotherapy who interprets tumor marker CA 19-9 tests at HCG Manavata Cancer Centre.

• Holds a Doctor of Medicine in radiotherapy from Banaras Hindu University
• Diplomate of the National Board in radiotherapy
• Member of the Association of Radiation Oncology of India
• Member of the Society for Neuro-Oncology
• Participates in the Indian Association of Hyperthermia Oncology

Dr. Chaitainya Borde has handled over 30,000 PET scans. He leads nuclear medicine services at the HCG Manavata Cancer Centre.

• Specializes in evaluating tumor marker CA 19-9 for cancer monitoring
• Expert in all types of nuclear scans and PET-CT imaging
• Experienced in treating thyroid cancer patients with specialized nuclear therapies
• Published scientific research in several medical journals
• Proficient in nuclear cardiology services and high-energy radioisotope treatments

Dr. Ahmer Arif Shaikh is a fellow-trained head and neck surgical oncologist. He specializes in organ preservation at the NABH-accredited HCG Manavata Cancer Centre.

• Performs lymphadenectomy to check for cancer spread during Tumor marker CA 19-9 testing
• Specialist in gastroectomy and complex surgeries for gastrointestinal and head cancers
• Fellow of Head and Neck Surgical Oncology from HCG Manavata Cancer Centre
• Published researcher in several national and international medical journals
• Focuses on functional rehabilitation to help patients recover after major surgeries

10,000 major surgeries performed – Dr. Lalit Banswal is a surgical oncologist and Assistant Professor at the State Cancer Institute.

• Specializes in gastrointestinal cancers where CA 19-9 levels help monitor pancreatic and stomach health
• Performs complex Whipple surgery to remove tumors from the head of the pancreas
• Expert in robotic and laparoscopic techniques for minimally invasive tumor removal
• Served as lead investigator for gastrointestinal oncology research at Tata Medical Center
• Fellowship trained in surgical oncology at the prestigious Tata Medical Centre in Kolkata

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre. He uses CA 19-9 testing to evaluate gastrointestinal cancers and plan targeted therapies.

• Earned a DNB in Medical Oncology from Indraprastha Apollo Hospital
• Specializes in the molecular basis of solid tumors for precise diagnosis
• Presented research on stomach cancer at the American Society of Clinical Oncology symposium
• Expert in treating complex gastrointestinal malignancies and hematological cancers
• Member of the American Society of Clinical Oncology (ASCO)

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries. He is the Chief of Surgical Oncology at HCG Manavata Cancer Centre in Nashik.

• Treats complex liver and pancreatic cases where Tumor marker CA 19-9 is often monitored
• Member of the Royal College of Surgeons of Edinburgh in the UK
• Participated in more than 200 Phase 1–3 clinical trials for cancer research
• Professor for DNB Superspecialty Surgical Oncology – trains other oncologists in the field
• Trained at Tata Memorial Hospital – India's premier center for cancer care